---
title: "Artificial intelligence in microbiology: implications for metagenomics, diagnostics, and AMR surveillance."
title_zh: 人工智能在微生物学中的应用：对宏基因组学、诊断和抗生素耐药性监测的影响
authors: "Renu Khangarot, Vandana Kumari, Rajeev Mishra, Abhijeet Singh"
date: 2026-04-11
pdf: "https://pubmed.ncbi.nlm.nih.gov/41965741/"
tags: ["query:pathoai"]
score: 10.0
evidence: 用于微生物学宏基因组、诊断和耐药性监测的AI方法
tldr: 针对微生物学中抗生素耐药性（AMR）监测和病原体分类的复杂挑战，本文综述了深度学习、Transformer序列模型及图神经网络等AI技术在基因组学和临床数据分析中的应用。通过整合多模态数据和可解释性AI技术，这些方法显著提升了耐药基因识别与表型预测的准确性。AI驱动的宏基因组分析为全球传染病监控和非侵入性诊断提供了高效、可扩展的解决方案，具有重大的公共卫生价值。
selection_source: fresh_fetch
motivation: 传统微生物分析难以高效处理海量的宏基因组和临床多模态数据，导致抗生素耐药性（AMR）的早期监测和精准诊断面临瓶颈。
method: 综述了利用Transformer、图神经网络及多模态架构对耐药基因进行标注，并结合SHAP等可解释性AI技术提升模型透明度的方法。
result: AI技术实现了对新型耐药基因的高灵敏度检测和耐药表型的精准预测，并推动了基于粪便微生物组的非侵入性诊断和实验室自动化。
conclusion: 尽管面临数据标准化和监管挑战，但AI与宏基因组学的深度融合将从根本上改变全球AMR监测策略，实现更早期的风险预警。
---

## 摘要
人工智能（AI）现已成为现代微生物学的关键参与者，它能够对基因组、宏基因组和临床数据进行高分辨率分析，用于传染病和抗生素耐药性（AMR）的监测。深度学习、基于 Transformer 的序列模型、图神经网络和多模态架构的显著进展，极大地提高了微生物分类的准确性、抗生素耐药基因（ARG）的检测以及耐药性预测。结合宏基因组测序，这些进展有助于开发灵敏、可扩展且非侵入性的方法，用于分析微生物组特征、鉴定新型耐药性并在群体层面监测 AMR 趋势。本综述总结了 AI 辅助微生物学的最新进展，特别强调了 AMR 监测。具体主题包括用于 ARG 注释的深度学习框架、识别新耐药基因的新兴方法，以及旨在改善表型预测的多模态应用（基因组和临床元数据）。文中探讨了宏基因组组装基因组（MAGs）在加强 AMR 监测工作中的作用，及其相对于分离株基因组的局限性。讨论部分还考察了包括 SHAP、注意力机制和基于梯度的归因方法在内的可解释人工智能（XAI）技术，旨在提高透明度和临床可解释性。此外，我们还涵盖了潜在的应用场景，包括 AI 赋能的非侵入性粪便微生物组诊断、实验室自动化和环境监测。尽管已取得显著进展，但在数据集差异、模型对数据集的依赖性、可解释性和监管审批方面仍存在待解决的问题。克服这些障碍需要标准化的工作流程框架、隐私保护联邦学习方法以及用于临床和公共卫生工具的可解释 AI 框架。AI 有望通过实现更早的耐药性检测、先进的风险评估建议以及改进全球监测策略，从根本上改变 AMR 监测。

## Abstract
Artificial intelligence (AI) is now a key player in modern microbiology, as it enables high-resolution analyses of genomic, metagenomic, and clinical data for the monitoring of infectious disease and antimicrobial resistance (AMR). Considerable advancements in deep learning, transformer-based sequence models, graph neural networks, and multimodal architectures have greatly improved microbial classification accuracy, antibiotic resistance gene (ARG) detection, and resistance prediction. Taking metagenomic sequencing into consideration, these advancements have contributed to the development of sensitive, scalable, and non-invasive methods to profile microbiomes, determine novel resistance, and monitor AMR trends at the population level. This review summarizes recent advances in AI-aided microbiology, with a particular emphasis on AMR surveillance. Specific topics include deep learning frameworks for ARG annotation, emerging approaches to identifying new resistance genes, and multimodal applications (genomic and clinical metadata) aimed at improving phenotype prediction. The role of metagenome-assembled genomes (MAGs) to enhance AMR surveillance efforts is noted, along with their noted limitations relative to isolate genomes. The discussion includes the examination of explainable AI (XAI) techniques including SHAP, attention mechanism approaches, and gradient-based attribution approaches, with the aim of increasing transparency and clinical explainability. We also cover potential applications including AI-enabled non-invasive fecal microbiome diagnostics, laboratory automation, and environmental surveillance. While there has been significant progress, unresolved issues exist relating to dataset variations, liability of models to datasets, interpretability, and regulatory approval. Overcoming these barriers, however, will require standardized frameworks for these workflows, privacy-preserving federated learning methods, and interpretable AI frameworks for clinical and public health tools. AI could fundamentally change AMR surveillance by allowing for earlier resistance detection, advanced risk assessment recommendation, and improved monitoring strategies globally.